Delivery Order SPE2DB22D3016-SPE2DB25FAAQ2

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $65K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D3004|SPE2DB25FPQ17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,600.96 firm fixed price delivery order is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of fingolimod 0.5 milligram capsules. The award, valued at $11,235.03, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,526.70 Firm Fixed Price Delivery Order covers the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,596.00 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 20, 2025, with a completion date of May 21, 2025. Amerisourcebergen Drug Corp also holds a...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,816.69 firm fixed price delivery order is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FW0RQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $37,938.28 and a completion date of May 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB7P4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,054.07 firm fixed-price delivery order is for the supply of 4,567,926,957 units of the medication Fingolimod 0.5 mg capsules. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,317.23, is for the delivery of Fingolimod 0.5 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a neurological medication, with a ceiling value of $28,649.02. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and was likely competed openly. AmerisourceBergen Drug Corp holds a...
This federal contract award of $62,452.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order with a completion date of November 19, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of providing pharmaceutical products and medical supplies to...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAAQ2
    Delivery Order

This federal contract award (SPE2DB22D3016|SPE2DB25FAAQ2) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a ceiling value of $65,226.74 and an ultimate completion date of October 16, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 1/14/25, 9:15 AM